Eun Joo Nam

USPTO Granted Patents = 6 (Patent Applications = 3)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

4 out of 4

Medifron Dbt Co., Ltd.

patents

3 out of 76

Daewoong Pharmaceutical Co., Ltd.

where one patent can have more than one assignee

Years Active: 2012-2022

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11339197 - Modified EGF protein, production method therefor, and use thereof (2022-05-24),

2. 11135262 - Methods of treating cervical cancer (2021-10-05),

3. 8580848 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-11-12),

4. 8507553 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-08-13),

5. 8455542 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2013-06-04),

6. 8263649 - Benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof (2012-09-11),

Title: Eun Joo Nam: Innovator in Protein Modification and Cancer Treatment

Introduction

Eun Joo Nam is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of modified proteins and cancer treatment methods. With a total of 6 patents, his work has the potential to impact medical treatments significantly.

Latest Patents

Eun Joo Nam's latest patents include a modified EGF protein, a production method therefor, and its use. This modified EGF protein allows for effective delivery into cells and exhibits an enhanced half-life span. The production method involves culturing conditions where the host cell growth phase and protein expression phase utilize different temperature conditions. Additionally, he has developed methods for treating cervical cancer, specifically targeting tumors caused by human papillomavirus (HPV) infection. His invention provides methods for improving cervical tumor treatment using a polynucleotide encoding an E6/E7 fusion protein.

Career Highlights

Throughout his career, Eun Joo Nam has worked with notable companies such as Medifron Dbt Co., Ltd. and Daewoong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in protein modification and cancer treatment.

Collaborations

Eun Joo Nam has collaborated with talented individuals in his field, including Dong Wook Kang and Jee Woo Lee. These collaborations have likely enhanced the innovation and development of his patented technologies.

Conclusion

Eun Joo Nam's contributions to biotechnology, particularly in protein modification and cancer treatment, showcase his innovative spirit and dedication to improving medical science. His patents reflect a commitment to advancing healthcare solutions that can benefit many patients.

This text is generated by artificial intelligence and may not be accurate.